ROCKET PHARMACEUTICALS, INC.
StreetZero Signal 44
About ROCKET PHARMACEUTICALS, INC.
Rocket Pharmaceuticals, Inc. is a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening disorders. The company focuses on developing gene therapies that correct the root cause of complex and rare childhood diseases through an integrated pipeline. It operates as a public company on NASDAQ under the ticker RCKT and is headquartered in Cranbury, New Jersey.
LATEST FUNDINGRule 144
$1K
Announced 2026-11-18
TOTAL RAISED$1.06B
IN THE NEWS
- ๐ Rocket Pharmaceuticals
- ๐ When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit?
- ๐ Rocket Pharmaceuticals Announces $26.4 Million Private Placement | Rocket Pharmaceuticals, Inc.
- ๐ Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital | Rocket Pharmaceuticals, Inc.
- ๐ Rocket Pharmaceuticals Inc โข Our companies โข RTW Investments
EMPLOYEESโ
FOUNDED2015
HQCranbury, New Jersey, United States
Industry
Public Equity (NASDAQ)
Tags
BiotechnologyGene TherapyPublic CompanyRare Diseases
Investors
Key highlights
- Raised $1.06B total across 16 funding rounds with prominent life science investors.
- RTW Investments led Series A and B and took the company public via reverse merger in 2018.
- Completed a $26.4M private placement in 2021 to advance its gene therapy pipeline.
- Secured up to $150M credit facility from Hercules Capital to support cardiovascular programs.
- Operates with no debt on balance sheet, relying on shareholder funding for its late-stage biotech activities.
Ask StreetZero about ROCKET PHARMACEUTICALS, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account